Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Young Adult Oncology”

833 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 833 results

Not applicableLooking for participantsNCT05314803
What this trial is testing

Yoga for Young Adults Affected by Cancer

Who this might be right for
Young Adult CancerYoung Adult Oncology
University of Calgary 500
Testing effectiveness (Phase 2)UnknownNCT02660762
What this trial is testing

Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL

Who this might be right for
Leukaemia,Lymphoblastic
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Study completedNCT03610724
What this trial is testing

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 34
Not applicableEnrolling By InvitationNCT04202094
What this trial is testing

Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

Who this might be right for
Childhood CancerHematological Disorders
Universitair Ziekenhuis Brussel 50
Not applicableStudy completedNCT04585269
What this trial is testing

Bright IDEAS - Young Adults Problem-Solving Skills Training

Who this might be right for
Cancer PatientsYoung AdultSupportive Care
Rutgers, The State University of New Jersey 344
Early research (Phase 1)Ended earlyNCT04751383
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT01445145
What this trial is testing

An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Looking for participantsNCT06709495
What this trial is testing

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Who this might be right for
SarcomaSarcoma, EwingDesmoplastic Small Round Cell Tumor+3 more
David S Shulman, MD 63
Early research (Phase 1)Looking for participantsNCT07573111
What this trial is testing

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute LeukemiaMyelodysplastic Syndrome
Laguna Biotherapeutics, Inc. 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03573700
What this trial is testing

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, Refractory
St. Jude Children's Research Hospital 24
Not applicableStudy completedNCT05440409
What this trial is testing

CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL

Who this might be right for
Leukemia, Acute LymphoblasticLymphoblastic Leukemia, Acute, Childhood
National Cancer Institute (NCI) 57
Not applicableStudy completedNCT03446105
What this trial is testing

Promoting Quality of Life Among Young Adult Cancer Survivors

Who this might be right for
Cancer
Emory University 57
Not applicableWithdrawnNCT02903277
What this trial is testing

National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Centre Hospitalier Universitaire de Nice
Testing effectiveness (Phase 2)Study completedNCT01462695
What this trial is testing

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Who this might be right for
Childhood Cerebellar Anaplastic AstrocytomaChildhood Cerebral Anaplastic AstrocytomaChildhood Cerebral Astrocytoma+8 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02981628
What this trial is testing

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent B Lymphoblastic LymphomaRefractory B Acute Lymphoblastic Leukemia+1 more
Children's Oncology Group 80
Early research (Phase 1)Ended earlyNCT02412475
What this trial is testing

Epigenetic Reprogramming in Relapse AML

Who this might be right for
Leukemia, Acute Myeloid
Michael Burke 3
Not applicableActive Not RecruitingNCT00832325
What this trial is testing

Adolescent and Young Adult Cancer Survivors: Identity Development

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center 300
Not applicableUnknownNCT05336318
What this trial is testing

Peer2Me: A Peer Supported Program for Adolescent and Young Adult Cancer Patients

Who this might be right for
CancerPsychosocial Problem
University of Leipzig 180
Testing effectiveness (Phase 2)Looking for participantsNCT04684368
What this trial is testing

A New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Who this might be right for
Central Nervous System Nongerminomatous Germ Cell TumorChoriocarcinomaEmbryonal Carcinoma+7 more
Children's Oncology Group 160
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Next Page